Skip to Content

Notice

National Cancer Institute; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4), and 552b(c) (6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Advisory Board Ad hoc Subcommittee on Managing Conflict of Interest: Facilitation of Industry Interactions.

Open: June 27, 2011, 1 p.m. to 5 p.m.

Agenda: Discussion on Managing Conflict of Interest and the Facilitation of Industry Interactions.

Place: Double Tree by Hilton Hotel Bethesda, The Grand Ball Room, 8120 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mr. Eric Hale, Executive Secretary, NCAB Ad hoc Subcommittee on Managing Conflict of Interest and Facilitation of Industry Interactions, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Suite 202, Bethesda, MD 20892-8345. (301) 496-1148.

Name of Committee: National Cancer Advisory Board Subcommittee on Clinical Investigations.

Open: June 27, 2011, 6 p.m. to 7:30 p.m.

Agenda: Discussion on Clinical Investigations.

Place: Bethesda Hyatt Regency Hotel, One Metro Center, Bethesda, MD 20814.

Contact Person: Dr. Jeff Abrams, Executive Secretary, NCAB Subcommittee on Clinical Investigations, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Room 7018, Bethesda, MD 20892-8345. (301) 496-6138.

Name of Committee: National Cancer Advisory Board.

Open: June 28, 2011, 9 a.m. to 3:30 p.m.

Agenda: Program reports and presentations; business of the Board.

Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. (301) 496-5147.

Name of Committee: National Cancer Advisory Board.

Closed: June 28, 2011, 3:45 p.m. to 5 p.m.

Agenda: Review of grant applications.

Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. (301) 496-5147.

Name of Committee: National Cancer Advisory Board.

Open: June 29, 2011, 9 a.m. to 12 p.m.

Agenda: Program reports and presentations; business of the Board.

Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. (301) 496-5147.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/​advisory/​ncab.htm, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; Start Printed Page 2707093.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Start Signature

Dated: May 3, 2011.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2011-11402 Filed 5-9-11; 8:45 am]

BILLING CODE 4140-01-P